BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
8.49
-0.16 (-1.85%)
Sep 11, 2026, 4:00 PM EDT - Market closed
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $389.66 million as of September 11, 2026. Its market cap has increased by 125.50% in one year.
Market Cap
389.66M
Enterprise Value
11.24M
1-Year Change
125.50%
Ranking
Category
Stock Price
$8.49
ChartMarket Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $389.66M, a decrease of -36.64%. That is a compound annual growth rate of -20.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 389.66M | -17.86% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 612.30M |
| Aquestive Therapeutics | 599.95M |
| Tilray Brands | 550.71M |
| Evolus | 517.84M |
| Kamada | 464.97M |
| Canopy Growth | 390.33M |
| Alpha Teknova | 360.25M |
| Emergent BioSolutions | 319.43M |